Serotonin type 3 receptor genes: HTR3A, B, C, D, E

Pharmacogenomics

Volumn 9, Issue 5, 2008, Pages 501-504

  Niesler, Beate ^a   Kapeller, Johannes ^a   Hammer, Christian ^a   Rappold, Gudrun ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; DOLASETRON MESILATE; GRANISETRON; ONDANSETRON; PALONOSETRON; PAROXETINE; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN 3A RECEPTOR; SEROTONIN 3B RECEPTOR; SEROTONIN 3C RECEPTOR; SEROTONIN 3D RECEPTOR; SEROTONIN 3E RECEPTOR; TROPISETRON;

ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; BULIMIA; CENTRAL NERVOUS SYSTEM; CHEMOTHERAPY INDUCED EMESIS; CHROMOSOME 11Q; CHROMOSOME 3Q; COGNITIVE DEFECT; DIARRHEA; FIBROMYALGIA; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; GENE ACTIVATION; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE LOCATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; INTESTINE SECRETION; IRRITABLE COLON; MAJOR DEPRESSION; MENTAL DISEASE; NAUSEA; NONHUMAN; PERISTALSIS; PHARMACOGENETICS; POSTOPERATIVE NAUSEA AND VOMITING; RHEUMATIC DISEASE; SCHIZOPHRENIA; STOICHIOMETRY;

ANIMALS; DATABASES, GENETIC; HUMANS; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; VARIATION (GENETICS);

EID: 44949237887     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.9.5.501     Document Type: Article

References (32)

1. Belelli D, Balcarek JM, Hope AG, Peters JA, Lambert JJ, Blackburn TP: Cloning and functional expression of a human 5-hydroxytryptamine type 3AS receptor subunit. Mol. Pharmacol. 48(6), 1054-1062 (1995).
2. Miyake A, Mochizuki S, Takemoto Y, Akuzawa S: Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species. Mol. Pharmacol. 48(3), 407-416 (1995).
3. Niesler B, Walstab J, Combrink S et al.: Characterization of the novel human serotonin receptor subunits 5-HT3C, 5-HT3D and 5-HT3E. Mol. Pharmacol. 72(1), 8-17 (2007).
4. Niesler B, Frank B, Kapeller J, Rappold GA: Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E. Gene 310, 101-111 (2003).
5. Davies PA, Pistis M, Hanna, MC et al.: The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature 397(6717), 359-363 (1999).
6. Dubin AE, Huvar R, D'Andrea MR et al.: The pharmacological and functional characteristics of the serotonin 5-HT(3A) receptor are specifically modified by a 5-HT(3B) receptor subunit. J. Biol. Chem. 274(43), 30799-30810 (1999).
7. Brady CA, Stanford IM, Ali I et al.: Pharmacological comparison of human homomeric 5-HT3A receptors versus heteromeric 5-HT3A/3B receptors. Neuropharmacology 41(2), 282-284 (2001).
8. Karnovsky AM, Gotow LF, McKinley DD et al.: A cluster of novel serotonin receptor 3-like genes on human chromosome 3. Gene 319, 137-148 (2003).
9. Gershon MD: Review article: serotonin receptors and transporters - roles in normal and abnormal gastrointestinal motility. Aliment. Pharmacol. Ther. 20(Suppl. 7) 3-14 (2004).
10. Chameau P, van Hooft JA: Serotonin 5-HT(3) receptors in the central nervous system. Cell Tissue Res. 326(2), 573-581 (2006).
11. Bloom FE, Morales M: The central 5-HT3 receptor in CNS disorders. Neurochem. Res. 23(5), 653-659 (1998).
12. Thompson AJ, Lummis SC: The 5-HT3 receptor as a therapeutic target. Expert Opin. Ther. Targets 11 (4), 527-540 (2007).
13. Galligan JJ: Ligand-gated ion channels in the enteric nervous system. Neurogastroenterol. Motil. 14(6), 611-623 (2002).
14. Aapro M: 5-HT(3)-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatment. Oncology 69(2), 97-109 (2005).
15. Gershon MD: Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome. J. Clin. Gastroenterol. 39(Suppl. 5), S184-S193 (2005).
16. Mawe GM, Coates MD, Moses PL: Review article: intestinal serotonin signalling in irritable bowel syndrome. Aliment, Pharmacol. Ther. 23(8), 1067-1076 (2006).
17. Niesler B, Weiss B, Fischer C et al.: Serotonin receptor gene HTR3A variants in schizophrenic and bipolar affective patients. Pharmacogenetics 11(1), 21-27 (2001).
18. Yamada K, Hattori E, Iwayama Y et al.: Distinguishable haplotype blocks in the HTR3A and HTR3B region in the Japanese reveal evidence of association of HTR3B with female major depression. Biol. Psychiat. 60(2), 192-201 (2006).
19. Niesler B, Flohr T, Nöthen MM et al.: Association between the 5' UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder. Pharmacogenetics 11(6), 471-475 (2001).
20. Melke J, Westberg L, Nilsson S et al.: A polymorphism in the serotonin receptor 3A (HTR3A) gene and its association with harm avoidance in women. Arch. Gen. Psychiat. 60(10), 1017-1023 (2003).
21. Iidaka T, Ozaki N, Matsumoto A et al.: A variant C178T in the regulatory region of the serotonin receptor gene HTR3A modulates neural activation in the human amygdala. J. Neurosci. 25(27), 6460-6466 (2005).
22. Krzywkowski K: Do polymorphisms in the human 5-HT3genes contribute to pathological phenotypes? Biochem. Soc. Trans. 34(Pt 5), 872-876 (2006).
23. Thompson AJ, Sullivan NL, Lummis SC et al.: Naturally occurring variations in the human 5-HT3A gene profoundly impact 5-HT3 receptor function and expression. Pharmacogenet. Genomics 17(4), 255-266 (2007).
24. Thompson AJ, Sullivan NL, Lummis SC: Characterization of 5-HT3 receptor mutations identified in schizophrenic patients. J. Mol. Neurosci. 30(3), 273-281 (2006).
25. Kurzwelly D, Barann M, Kostanian A et al.: Pharmacological and electrophysiological properties of the naturally occurring Pro391Arg variant of the human 5-HT3A receptor. Pharmacogenetics 14(3), 165-172 (2004).
26. Frank B, Niesler B, Nöthen MM et al.: Investigation of the human serotonin receptor gene HTR3B in bipolar affective and schizophrenic patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 131(1), 1-5 (2004).
27. Krzywkowski K, Davies PA, Feinberg-Zadek PL, Bräuner-Osborne H, Jensen AA: High-frequency HTR3B variant associated with major depression dramatically augments the signaling of the human 5-HT3AB receptor. Proc. Natl Acad. Sci. USA 105(2), 722-727 (2008).
28. Meineke C, Tzvetkov MV, Bokelmann K et al.: Functional characterization of a-100-102delAAG deletion-insertion polymorphism in the promoter region of the HTR3B gene. Pharmacogenet. Genomics 18(3), 219-230 (2008).
29. Kaiser R, Tremblay PB, Sezer O, Possinger K, Roots I, Brockmöller J: Investigation of the association between 5HHT3A receptor gene polymorphisms and efficiency of antiemetic treatment with 5-HT3 receptor antagonists. Pharmacogenetics 14(5), 271-278 (2004).
30. Tremblay PB, Kaiser R, Sezer O et al.: Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients. J Clin. Oncol. 21(11), 2147-2155 (2003).
31. Sugai T, Suzuki Y, Sawamura K, Fukui N, Inoue Y, Someya T: The effect of 5-hydroxytryptamine 3A and 3B receptor genes on nausea induced by paroxetine. Pharmacogenomics J. 6(5), 351-356 (2006).
32. Kato M, Fukuda T, Wakeno M et al.: Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients. Neuropsychobiology 53(4), 186-195 (2006).